Invesco, a Atlanta-based investment management firm, bought up another clutch of Smith & Nephew (FTSE:SN, NYSE:SNN) shares, taking its total stake in the British medical device company to nearly 12%, according to regulatory filings.
becton dickinson
Becton Dickinson CFO leaves to pursue “entrepreneurial opportunity” | Personnel Moves
Hologic’s Gen-Probe subsidiary notches legal win over Becton, Dickinson
Abiomed: Medicare coverage decision unlikely for Impella | Wall Street Beat
Becton Dickinson aims to boost prefilled syringe business with Safety Syringes buyout
Becton Dickinson & Co. (NYSE:BDX) signed a definitive agreement to acquire Safety Syringes, maker of anti-needlestick devices for pre-filled syringes.
The merger, the terms of which were not disclosed, should close by the end of fiscal 2012, according to a press release.
Becton CEO Forlenza takes chairman seat | Personnel Moves
More deals ahead for Covidien? | Wall Street Beat
BD dips on Q2 results
Becton Dickinson & Co. (NYSE:BDX) shares lost about 1% today after the medical products maker reported lackluster 2nd-quarter results, despite beating Wall Street’s earnings expectations by a penny.
VLV sues Becton, Dickinson over ‘bloodless catheter’ patent | Legal News
Becton Dickinson & Co. (NYSE:BDX) is facing a patent infringement lawsuit filed by VLV Assoc., a small medical device company based in New Jersey, accusing it of infringing VLV’s patent for a "bloodless catheter."
Medtronic wins pain pump case on preemption | Legal News
Lost lawsuit pushes HemCon Medical into bankruptcy | Wall Street Beat
HemCon Medical Technologies said it’s filing for Chapter 11 bankruptcy protection for its U.S. operation after losing a $34.2 million court decision last month, saying it plans to appeal the ruling.
In March a sharply split U.S. Court of Appeals for the Federal Circuit reversed course and reinstated a win for Marine Polymer Technologies in its wound dressing patent spat with HemCon.